Skip to main content
Clinical Trials/NCT06806618
NCT06806618CompletedNot Applicable

Survey Evaluating the Burden and Management of HAE Crises by Patients and Caregivers

University Hospital, Grenoble1 site in 1 country300 target enrollmentStarted: March 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
To describe the burden associated with the on-demand treatment of HAE attacks

Study Overview

Brief Summary

The study has been designed as a French, multicentric survey study to obtain data to describe the burden of on-demand treatment for patients with hereditary angioedema (HAE). The online survey assesses various aspects of HAE and in particular the burden of HAE from the patients' and caregivers' perspectives.

Detailed Description

The study has been designed as a French, multicentric survey study to obtain data to describe the burden of on-demand treatment for patients with hereditary angioedema (HAE). The study will also explore the burden related to the administration of intravenous or subcutaneous on-demand treatments. The study was designed to collect data concerning the burden of HAE in patients with HAE (during HAE attacks and between attacks) and in caregivers. The online survey will collect data to describe the characteristics of patients with HAE, the disease characteristics, details concern various aspects of HAE attacks, and the burden of HAE in patients and their caregivers.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
12 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •For the patient population:
  • •Patients with a confirmed diagnosis of HAE with a deficit in the C1 inhibitor.
  • •Aged ≥12 years
  • •Having consulted for HAE in the last 3 months and with a medical file.
  • •For the caregiver population:
  • •1. A person identified by the patient as part of their support group and who provides support with the management of the patients HAE (including family members, friends, spouse, etc.)

Exclusion Criteria

  • •For the patient population:
  • •Opposes to participating in the study.
  • •Patients is under guardianship or deprived of their liberty.

Arms & Interventions

Patients with HAE

Patients will complete an online survey.

Outcomes

Primary Outcomes

To describe the burden associated with the on-demand treatment of HAE attacks

Time Frame: The survey will focus on HAE attacks that have occurred within the last 12 months.

The burden associated with the on-demand treatment of HAE attacks from the patient's and caregiver's perspective, will be described in terms of: * The frequency of HAE attacks. * The severity of HAE attacks. * Disease control. * Events that trigger the HAE attacks. * Frequency of injections for treating HAE attacks. * Delay in injections for treating HAE attacks. * Hospitalization for HAE attacks. * Impact on quality of life (during HAE attacks). * Impact on quality of life (between HAE attacks). * Social impact. * Financial impact. * Burden of the caregivers.

Secondary Outcomes

  • Use of on-demand treatments for HAE attacks(The survey will focus on HAE attacks that have occurred within the last 12 months.)

Investigators

Sponsor
University Hospital, Grenoble
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

HAE Burden and Crisis Management | Clinical Trial